Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with short ...
An inside look at an opaque process by Paul Gompers, Will Gornall, Steven N. Kaplan and Ilya A. Strebulaev Over the past 30 years, venture capital has been a vital source of financing for high-growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback